Ralph H.M. Hermans

Radboud University Nijmegen — Netherlands

Medicine · Health Sciences

21h-index3.8kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(22), Intraperitoneal and Appendiceal Malignancies(15), Endometrial and Cervical Cancer Treatments(14), Cervical Cancer and HPV Research(10), Colorectal and Anal Carcinomas(5)

Publications53 total

MRI in advanced ovarian cancer: multicentre MISSION trial.
European Journal of Cancer·2026
Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer
International Journal of Gynecological Cancer·2026
Reduction of screen induced myopia by parental interventions
European Journal of Public Health·2024Open Access
PR026/#477  Diagnostic performance of DW-MRI in advanced ovarian cancer: first results of the Dutch prospective multicenter mission trial
2024
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer (OVHIPEC-1): Final Survival Analysis of a Randomised, Controlled, Phase 3 Trial
Obstetrical & Gynecological Survey·2024Open Access
A Prospective Multicentre Trial Evaluating the Role of MRI in the Diagnostic Workup of Advanced Ovarian Cancer: The Mission Trial
SSRN Electronic Journal·2024Open Access
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
The Lancet Oncology·2023· 102 citedOpen Access
Final survival analysis of the phase III OVHIPEC-1 trial of hyperthermic intraperitoneal chemotherapy in ovarian cancer after ten year follow-up.
Journal of Clinical Oncology·2023· 1 cited
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe
Gynecologic Oncology·2022· 17 citedOpen Access
Effect of <scp>HIPEC</scp> according to <scp>HRD</scp>/<scp><i>BRCA</i>wt</scp> genomic profile in stage <scp>III</scp> ovarian cancer: Results from the phase <scp>III OVHIPEC</scp> trial
International Journal of Cancer·2022· 40 citedOpen Access
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II
Journal of Clinical Oncology·2021· 114 citedOpen Access
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer
International Journal of Gynecological Cancer·2020· 10 citedOpen Access
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study
Gynecologic Oncology·2020· 23 citedOpen Access
Radiotherapy as an alternative treatment for inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II
Gynecologic Oncology·2020· 5 cited
EP1009 Loss of skeletal muscle mass during neo-adjuvant chemotherapy and the relation to survival in patients with ovarian cancer; a prospective analysis of the OVHIPEC-1 cohort
2019
Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II
2019· 25 cited
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Obstetrical & Gynecological Survey·2019· 3 cited
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
Journal of Clinical Oncology·2019· 54 citedOpen Access
Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer
European Journal of Surgical Oncology·2019· 59 citedOpen Access
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Obstetrical & Gynecological Survey·2018· 56 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Willemien J. van Driel(22), Jacobus van der Velden(19), Henriëtte J.G. Arts(17), Gabe S. Sonke(15), Simone N. Koole(14), Henk W.R. Schreuder(14), Ignace H. J. T. de Hingh(14), Jules H. Schagen van Leeuwen(12), Arend G. J. Aalbers(12), Katja N. Gaarenstroom(12), Karolina Sikorska(10), Victor J. Verwaal(10), Koen Van de Vijver(10), Neil K. Aaronson(10), Johanna M.A. Pijnenborg(9), Maaike H.M. Oonk(8), Joanne A. de Hullu(8), Ignace Vergote(8), Jacobien M. Kieffer(7), Peter Baldwin(7)